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ABSTRACT Linear dichroism of 5-tetramethylrhodamine (5ATR)-labeled cardiac troponin C (cTnC) was measured to
monitor cTnC structure during Ca2-activation of force in rat skinned myocardium. Mono-cysteine mutants allowed labeling
at Cys-84 (cTnC(C84), near the D/E helix linker); Cys-35 (cTnC(C35), at nonfunctional site I); or near the C-terminus with a
cysteine inserted at site 98 (cTnC-C35S,C84S,S98C, cTnC(C98)). With 5ATR-labeled cTnC(C84) and cTnC(C98) dichroism
increased with increasing [Ca2], while rigor cross-bridges caused dichroism to increase more with 5ATR-labeled cTnC(C84)
than cTnC(C98). The pCa50 values and nH from Hill analysis of the Ca
2-dependence of force and dichroism were 6.4 (0.02)
and 1.08 (0.04) for force and 6.3 (0.04) and 1.02 (0.09) (n  5) for dichroism in cTnC(C84) reconstituted trabeculae.
Corresponding data from cTnC(C98) reconstituted trabeculae were 5.53 (0.03) and 3.1 (0.17) for force, and 5.39 (0.03)
and 1.87 (0.17) (n  5) for dichroism. The contribution of active cycling cross-bridges to changes in cTnC structure was
determined by inhibition of force to 6% of pCa 4.0 controls with 1.0 mM sodium vanadate (Vi). With 5ATR-labeled cTnC(C84)
Vi caused both the pCa50 of dichroism and the maximum value at pCa 4.0 to decrease, while with 5ATR-labeled cTnC(C98)
the pCa50 of dichroism decreased with no change of dichroism at pCa 4.0. The dichroism of 5ATR-labeled cTnC(C35) was
insensitive to either Ca2 or strong cross-bridges. These data suggest that both Ca2 and cycling cross-bridges perturb the
N-terminal structure of cTnC at Cys-84, while C-terminal structure is altered by site II Ca2-binding, but not cross-bridges.
INTRODUCTION
In skeletal and cardiac muscle, the force-generating inter-
action between myosin and actin is inhibited by the tropo-
nin/tropomyosin complex on the thin filaments. The ability
to generate force by myosin cross-bridges is regulated by
myoplasmic [Ca2]. Ca2 binds to the thin filament regu-
latory protein, troponin C (TnC; one of three subunits of
troponin), relieving the inhibition of myosin cross-bridge
binding by the troponin/tropomyosin complex, and placing
the thin filament in the “on state,” thereby allowing strong
cross-bridge binding and force generation (Lehrer, 1994;
Tobacman, 1996; Gordon et al., 2000). Furthermore, there
is significant structural (Vibert et al., 1997) and biochemical
(McKillop et al., 1993; Geeves and Lehrer, 1994) evidence
that, while Ca2 binding to TnC allows the initial cross-
bridge binding, subsequent strong cross-bridge interaction
may be required for maximum availability of myosin bind-
ing sites on actin. Thus, strong cross-bridge binding may
play an important role in thin filament activation, presum-
ably by inducing structural changes in thin filament regu-
latory proteins that allow the thin filaments to more fully
attain the “on” state for activation of contraction. In cardiac
muscle the role cross-bridges play in facilitating thin fila-
ment activation may be even more dominant than in skeletal
muscle, as the Ca2-affinity of cTnC is increased during
force generation (Hofmann et al., 1987b; Pan and Solaro,
1987; Wang and Fuchs, 1994).
Although the gross myofilament structure of skeletal and
cardiac muscle is similar, and the basic mechanisms of
regulation of contraction by Ca2 have similar molecular
architectures, there are important differences in thin fila-
ment activation between skeletal and cardiac muscle (Gor-
don et al., 2000). In cardiac muscle cycling cross-bridge
attachment significantly enhances the apparent affinity of
TnC for Ca2 and thin filament activation in cardiac muscle
(Hofmann et al., 1987b; Pan and Solaro, 1987; Wang and
Fuchs, 1994). By contrast, in skeletal muscle active cross-
bridge binding neither enhances Ca2 binding (Fuchs and
Wang, 1991; Wang and Fuchs, 1994) nor induces structural
changes in TnC (Martyn et al., 1999). These results imply
that if cycling cross-bridge binding activates thin filaments
in skeletal muscle, the structure of TnC is uncoupled from
this process (Martyn et al., 1999). In contrast to cycling
cross-bridges, the effects of rigor cross-bridge binding on
thin filament activation are similar in skeletal and cardiac
muscle. For example, rigor cross-bridges induce structural
changes in sTnC (Zot and Potter, 1987; Allen et al., 1992;
Martyn et al., 1999) and cTnC (Hannon et al., 1993; Putkey
et al., 1997), and enhance thin filament activation (Brandt et
al., 1990; Metzger, 1995) and Ca2-binding (Bremel and
Weber, 1972; Fuchs, 1977; Hofmann and Fuchs, 1987a; Pan
and Solaro, 1987) in both tissues. These observations make
it difficult to directly compare the effects of thin filament
activation by cycling and rigor cross-bridges. Taken to-
gether, the evidence suggests that, while thin filament acti-
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vation by rigor cross-bridges may occur by similar mecha-
nisms, the role of strong, cycling cross-bridge binding in
thin filament activation and regulation of contraction may
be different in skeletal and cardiac muscle.
The goal of this study is to compare the effects on cTnC
structure of Ca2 binding to the single regulatory site (site
II) on cardiac TnC (cTnC) with that of cycling, force-
generating cross-bridges. Because, upon Ca2 binding to
site II, cTnC undergoes a complex series of interactions
between the other subunits of the troponin complex, TnI and
TnT (Farah and Reinach, 1995; Solaro and Rarick, 1998),
we have used mono-cysteine mutants of cTnC to monitored
the structure of cTnC at three sites; (1) at site I, in the
N-terminus, with cTnC(C35); (2) near the junction of the
D/E helixes, with cTnC(C84); and (3) at the C-terminus of
cTnC, with insertion of a cysteine residue at site 98, near the
structural Ca2/Mg2 site III, with mono-cysteine mutant
cTnC(C98). We used a “skinned” cardiac preparation,
which enables us to control myoplasmic [Ca2] and ex-
change fluorescently labeled cTnC for endogenous cTnC.
Ca2- and cross-bridge-dependent changes in cTnC struc-
ture were monitored by measuring the dichroism of 5-
tetramethyl-rhodamine (5ATR), which was attached to the
single cysteine residue in each cTnC mutant. The dichroism
signal could indicate the mobility or order of the probe in its
local environment on cTnC, the degree of order of the
troponin complex, or the degree of order or orientation of
the entire troponin/tropomyosin complex. In a complemen-
tary subset of experiments, cTnC(C84) structure was moni-
tored with 2-(4-iodoacetamidoanilo)naphthalene-6-sulfonic
acid (IAANS), which is sensitive to the hydrophobicity or
solvent accessibility of its environment. To allow separation
of the effects of Ca2-binding and cross-bridge attachment
on cTnC structure, cross-bridge attachment and force were
inhibited with 1.0 mM sodium vanadate (Vi). Vi was chosen
because inhibition of force and stiffness was nearly complete.
The results indicate that attachment of cycling cross-
bridges is an important modulator of cTnC Ca2 binding
properties and cardiac thin filament activation. However,
while the structure of cTnC is sensitive to both Ca2 bind-
ing and cycling cross-bridge attachment, the responsiveness
depends on the site of attachment of the fluorescent probe.
The probe is sensitive to both Ca2 and cross-bridges when
attached near Ca2-regulatory site II, and only to Ca2
binding to site II when attached at the C-terminus, and lacks
sensitivity to either when attached near the nonfunctional
site I of cTnC.
MATERIALS AND METHODS
Preparation and solutions
Male Sprague-Dawley rats (150–250 g) were anesthetized with an intra-
peritoneal injection of pentobarbital (50 mg/kg) and their hearts removed
rapidly and placed in oxygenated Ringer’s solution. Small trabeculae
(100–200 m diameter, 1–2 mm length) were dissected from the right
ventricle and their surface membranes rendered permeable to bathing
solution constituents by exposing them for at least 30 min at room tem-
perature to a solution containing (in mM): 100 KCl, 9.0 MgCl2, 4.0
MgATP, 5.0 K2EGTA (ethylene glycol-bis-(b-aminoethylether)-N,N,N,N-
tetraacetic acid), 10 MOPS (3-(n-morpholino) propane sulfonic acid), 1%
non-ionic detergent Triton X100, pH 7.0, and 50% v/v glycerol. The
skinned trabeculae were stored in the same solution without Triton X-100
at 20°C and used for experiments within 1 week. Experimental temper-
ature was 20°C.
The composition of solutions was determined according to an iterative
computer program that calculates the equilibrium concentration of ligands
and ions based on published affinity constants. MOPS was used as the pH
buffer and its concentration varied to maintain constant ionic strength.
Ca2 and K were added primarily as the propionate salts. Rigor solutions
contained no MgATP, creatine phosphate (CP), or creatine phosphokinase
(CPK). All other solutions contained (in mM): EGTA 15; Mg2 1; MgATP
3; Na 38; K 95; CP 20; and 60 units/ml CPK.
Mechanical and fluorescence measurements
A detailed description of our optical and mechanical apparatus can be
found in Martyn et al. (1999). The force transducer, length changer, and
flow chamber for the skinned preparations are mounted on the moveable
stage of an inverted epi-fluorescence microscope (Zeiss Axiovert 35).
Initial sarcomere length was monitored by HeNe laser diffraction and set at
2.4 m. In some experiments stiffness was measured by low-amplitude
(0.2%) sinusoidal oscillations (500 Hz) of preparation length. Proprietary
software was used to determine stiffness from Fourier analysis of the
resulting force trace.
Quantitative epi-fluorescence measurement was made using a Zeiss
Axiovert 35 microscope. The excitation light (HBO 50/3, OSRAM GmbH,
Germany) was passed through an excitation filter, which is appropriate for
the fluorophore being used and a 10 objective (Neofluor), which func-
tioned as the condenser. The emitted light was collected by the same
objective and passed through an appropriate band-pass filter to the photo-
multiplier (R928HA, Hamamatsu Photonics KK, Japan). Fluorescence
(FL) and isometric force were recorded simultaneously on a chart recorder
and stored digitally by computer. The background FL (that obtained
without the fiber in the optical path) was subtracted from all measurements,
and FL changes were expressed relative to that observed under relaxing
conditions.
For excitation of 5IATR-labeled TnC the fiber was illuminated by a
mercury vapor lamp (HBO 50/3, OSRAM GmbH, Germany) filtered at
540  5 nm, then passed through a 12% neutral density and polarizing
filter oriented perpendicular to the fiber axis. The plane of polarization of
the excitation illumination was alternated at 84 kHz by a photo-elastic
modulator (Model PEM 80, Hinds Int’l., Portland, OR), with the peak-to-
peak retardation set to 413 nm. The amount of light absorbed by the probes
was determined by measuring the emitted light (590–630 nm), which will
be focused onto a photomultiplier tube (Hamamatsu Type R938HA,
Hamamatsu City, Japan). The output of the photomultiplier was monitored
with a wide band-pass current to voltage converter (3 db at 450 kHz).
Because reflecting surfaces were present in both the excitation and emis-
sion optical paths, it was necessary to compensate each path for the
preferential reflection of light polarized perpendicular to the fiber axis.
This was accomplished with compensating windows consisting of two
closely spaced glass plates. The windows could be angled so as to make the
transmission of light polarized in either direction equal in both paths. To
determine the rms amplitude of the sinusoidally varying difference in
fluorescence intensity parallel (I) and perpendicular (I) to the fiber axis,
the output of the amplifier was directed to a lock-in amplifier (Ithaco
Model 3961B, Ithaca, NY). Dichroism or polarization anisotropy (r) were
measured and expressed using the equation given by Tanner et al. (1992),
as:
r 2D/L	/6J2	 1 3J0	D/L	
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where D is the rms value of I  I (from the output of the lock-in
amplifier) and L is the total fluorescence (I  2I). The retardation of the
photo-elastic modulator was set so that the zeroth order Bessel function
(J0) was zero. Further details are in Martyn et al. (1999).
The relation among force, fluorescence, and [Ca2] for each fiber were
fitted by a nonlinear least-squares regression to the Hill equation, using
SigmaPlot 5.0 (Jandel Corp., Chicago, IL):
Relative force or fluorescence
1
1 10nHpCapCa50	
where pCa50 is the negative log of the [Ca2] that produces half-maximal
force or fluorescence and nH describes the slope of the Ca2 dependence.
The data from individual fibers were averaged and statistical analyses were
performed using Excel (Windows 95, Microsoft Corp., Redmond, WA).
Student’s t-test was used to compare the means of data, with p 
 0.05
considered significant.
cTnC extraction and reconstitution
Native cTnC was extracted from the skinned cardiac trabeculae by expos-
ing them to a low ionic strength solution that contained (in mM): K2EDTA
5; TRIS 20; and pH 7.2 (Gulati et al., 1991). To begin cTnC extraction the
fiber was first placed in relaxing solution at 5–8°C, then rigor solution
(zero [ATP]) at the low temperature. The length of the preparation was
decreased to relieve rigor tension. The temperature was then raised to 30°C
and the rigor solution was replaced with extraction solution at 30°C for
30–50 min. After cTnC extraction the procedure was reversed. Both the
rigor and extraction solutions contained 5.0 mM BDM. After extraction the
fiber was placed in relaxing solution at 20°C, and Ca2-activated force was
determined in pCa 4.0 activating solution. Post-extraction force was 20 
5% (mean  SEM; n  27 preparations) of pre-extraction maximum
values. Trabeculae were then reconstituted by incubation for 30 min in a
relaxing solution (zero added Ca2), containing 10–50 M fluorescently
labeled cTnC. After reconstitution with fluorescently labeled mono-cys-
teine mutant, TnC force at pCa 4.0 was 80  7.1% (mean  SEM; n  24
preparations) of pre-extraction maximum force.
Protein preparation and labeling
Preparation of mutant TnC’s
Mono-cysteine mutants of cTnC that were made for specific place-
ment of fluorescent probes are cTnC(C35S), cTnC(C84S), and
cTnC(C35S,C84S,S98C). To facilitate easy identification of the fluores-
cent probe attachment, these mono-cysteine cTnC mutants are referred to
as cTnC(C84), cTnC(C35), and cTnC(C98), respectively. The procedure
for mutant cTnC preparation is also described in Dong et al. (1996).
A vector pET-24 (Novagen) containing the T7 promoter, lac operator,
and a kanamycin resistance gene were used for the expression of cardiac
TnC cDNA. The purified TnC cDNA digested with the restriction enzymes
was ligated into the polylinker sites of pET-24. The recombinant DNA was
then transformed into a cloning strain HMS 174 (Novagen). Transformed
cells were grown on LB agar plated in the presence of kanamycin. Colonies
were screened for inserts by digestion with the restriction enzymes. This
procedure allowed us to check the construct insert before transforming
recombinant plasmid into an expression host. The recombinant DNA
(vector plus target gene) was subsequently transformed into host strain
BL21(DE3) lysogen (Novagen) containing a gene induced by isopropyl-
1-thio-b-D-galactopyranoside (IPTG) to synthesize T7 RNA polymerase.
Transformed cells were grown on LB agar plates in the presence of
kanamycin. A single colony was picked and inoculated into LB medium
containing kanamycin at 37°C until the OD600 reached 0.8. IPTG was then
added to a final concentration of 1 mM to induce the expression of target
protein. The induced culture was incubated for at least 3 more hours and
harvested by centrifugation. The cells were washed once with 50 mM Tris
(pH 8.0), 2 mM EDTA, and then re-suspended in a solution containing 2.4
M sucrose, 1% Triton X-100, 50 mM Tris (pH 7.0), 10 mM EDTA, 1 mM
DTT, and 0.5 mg/ml lysozyme. The cell suspension was placed on ice for
60 min and then sonicated for 5 min. The solution was centrifuged at
12,000  g for 20 min at 4°C. An equal volume of 2 SDS sample buffer
was added to an aliquot of sample from the supernatant for SDS gel
analysis. The supernatant was exhaustively dialyzed against a buffer con-
taining 6 M urea, 50 mM Tris (pH 8.0), 1 mM EGTA, 1 mM DTT before
loading onto a DEAE-52 column equilibrated with the same urea buffer.
Pure troponin C was eluted from the column with a linear gradient of
0–0.5 M KCl. TnC mutants were prepared by site-directed mutagenesis
and their expression was done using T7-GEN In Vitro Mutagenesis Kit
(United States Biochemical). The mutant proteins were expressed in the
pET system, as mentioned above. The identity of the recombinant proteins
was verified by DNA sequencing analysis. The purity of wild-type and
mutant TnCs was determined on SDS-polyacrylamide gel electrophoresis.
5ATR labeled cTnC
cTnC was dissolved in a buffer containing (in mM) 100 KCl, 20 TRIS, 1
ethylenediamine-N,N,N,N-tetraacetic acid (EDTA) and pH 8.0. Ten mM
DTT was added and the solution was cooled for 3–4 h. The protein was
then dialyzed against the same buffer without DTT for 12 h with three
solution changes to remove DTT. 5IATR (20 mM in dimethylformamide)
was added in 2 molar excess over TnC and the solution gently shaken at
10°C for 4 h. 5ATR was kindly provided by John Corrie (Corrie and
Craik, 1994). Finally, the labeled protein in buffer was dialyzed (3 times
for 4 h apiece) against a buffer containing (in mM) 130 potassium propri-
onate, 50 MOPS, 1 EGTA, pH 7.0.
IAANS-labeled cTnC
The mono-cysteine mutant cTnC-C35S was labeled with IAANS, as we
previously described (Hannon et al., 1992). For fluorescence measurements
skinned preparations with IAANS labeled cTnC were illuminated at 360
nm and the emitted light was filtered and collected at 520  40 nm.
RESULTS
Force and fluorescence measurements
The Ca2-dependence of force and fluorescence were mea-
sured in detergent-skinned right ventricular trabeculae from
rat hearts. Endogenous cTnC was extracted and the prepa-
rations were reconstituted with mono-cysteine mutants of
cTnC, in which the single cysteine was labeled with 5-
ATR. The use of mono-cysteine mutants of cTnC allowed
localization of the fluorescent probe at specific sites, en-
abling us to monitor localized Ca2- and cross-bridge-
induced changes in cTnC structure. The average length and
diameter of the skinned trabeculae used in this study were
1.75  0.07 mm and 145  9.8 m (means  SEM; n 
24), respectively. Initial sarcomere length was set at 2.4 m.
When it was possible to monitor sarcomere structure by
laser diffraction during maximal activation, sarcomere
length decreased to 2.1 m.
The experimental protocol is illustrated in Fig. 1 by
representative traces of force (top trace) and fluorescence
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obtained under relaxed and maximal Ca2-activated condi-
tions, and at a submaximal level of Ca2-activation (pCa
6.1), in a preparation that was reconstituted with 5ATR-
labeled cTnC(C84). The middle traces of Fig. 1 indicate the
difference in 5ATR emission parallel and perpendicular to
the preparation axis, while the bottom fluorescent traces
indicate the level of total fluorescence. Dichroism is ex-
pressed as the ratio of the difference trace to the total
fluorescent intensity. Total fluorescence exhibited little de-
pendence on Ca2, except for a small increase at pCa 4.0
(
5%), which was probably related to internal shortening of
sarcomeres and the accompanying increase in the amount of
fluorescent label in the field of view. By comparison, the
difference signal (Fig. 1, middle traces) increased signifi-
cantly, indicating an approximately twofold increase in di-
chroism. The increase in dichroism indicates either an in-
crease in the order of the probe (or a decrease in probe
mobility), or a change in average probe angle. During Ca2
activation of force, dichroism increased in preparations that
were reconstituted with either 5ATR-labeled cTnC(C84) or
cTnC(C98) (see Table 1).
Comparisons of the Ca2-sensitivity of force before ex-
traction of native cTnC and reconstitution with either native
cTnC or cTnC(C84) indicated that neither the extraction/
reconstitution protocol nor substitution of cTnC(C84) for
native cTnC had a significant effect on force-pCa relations
(data not shown). The similarity of Ca2-sensitivity of force
for native and cTnC(C84) is consistent with previously
published data that the substitution of serine for cysteine at
site 35 has no significant effect on either the equilibrium
binding or kinetics of Ca2-binding at site II of isolated
IAANS-labeled cTnC (Dong et al., 1996; Hazard et al.,
1998) or the maximum level of cardiac myofibrillar ATPase
activity (Putkey et al., 1993). However, we found that
extraction of endogenous cTnC and replacement with
5ATR-labeled cTnC(C84) in skinned trabeculae caused a
0.14  0.07 (mean  SEM; n  4 fibers) pCa unit increase
of the pCa50 of force and no significant change in nH. This
indicates that the 5ATR probe caused some perturbation of
cTnC structure when attached at Cys-84.
Effects of maximal Ca2-activation and strong
cross-bridge binding on mono-cysteine mutants
of cTnC
To compare the effects of Ca2 and cycling and non-cycling
cross-bridges on TnC structure, we measured force and
FIGURE 1 Force (top trace) and fluo-
rescence (bottom trace) changes at relax-
ing (pCa 9.2), and maximal (pCa 4.0) or
submaximal (pCa 6.1) [Ca2] are shown
for detergent-skinned right ventricular tra-
beculae from rat. The middle trace is the
output from the lock-in amplifier, indicat-
ing the difference in emission with excita-
tion parallel and perpendicular to the fiber
axis (I  I). The bottom trace represents
total fluorescence (I  2I). The scale of
the (I  I) trace is 10 times that for total
fluorescence. Changes in pCa (arrows) are
indicated below the bottom trace. The
shutters for the excitation lamp and photo-
multiplier tube were open for 2 s. The
closed circle indicates background mea-
surement, with the preparation out of the
field of view. Experimental temperature
was 20°C. The vertical calibration corre-
sponds to 200 mN/mm2 and the horizontal
bar indicates 1 min.
TABLE 1 Absolute dichroism (anisotropy) and relative changes in dichroism (mean  SEM) resulting from activation with Ca2
(pCa 4.0) and rigor cross-bridge binding, in the absence (9.2R) and presence (4.0R) saturating [Ca2]
Mutant cTnC
Number of
Trabeculae Dichroism (9.2)* 4.0† 9.2R† 4.0R†
cTnC(C84) 6 0.05  0.002 1.86  0.05 1.60  0.05 1.78  0.06
cTnC(C98) 5 0.03  0.003 2.52  0.16 1.21  0.08 1.88  0.12
cTnC(C35) 3 0.03  0.005 0.93  0.05 1.04  0.04 1.03  0.03
*Absolute value of dichroism at pCa 9.2.
†Expressed as a fraction dichroism obtained in relaxing solution (pCa 9.2).
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corresponding changes in cTnC structure (dichroism) dur-
ing thin filament activation by Ca2 and rigor cross-bridge
binding. The results are illustrated in Fig. 2, in which
changes in force are expressed as a fraction of the maximum
level at pCa 4.0 (after reconstitution with labeled cTnC) and
changes in dichroism are expressed relative to values ob-
tained at pCa 9.2. With the 5ATR label attached to Cys-84
(cTnC(C84)), dichroism increased twofold upon maximal
Ca2-activation of force (pCa 4.0) (Fig. 2 A). As shown in
Fig. 2 A, rigor without Ca2 (9.2R) caused dichroism to
increase to 65% of that found for Ca2-activation plus
cycling cross-bridges (4.0). Addition of Ca2 (4.0R) to
trabeculae in rigor caused a further small increase in dichro-
ism (p 
 0.05). Thus, with the 5ATR probe attached to
Cys-84, the structure of cTnC appears to be altered by both
Ca2 and strong cross-bridge binding.
When the 5ATR probe is attached to Cys-98 (cTnC(C98)),
near Ca2/Mg2 binding site III, dichroism increases2.5-
fold during maximal Ca2-activated force in reconstituted
trabeculae, as illustrated in Fig. 2 B (4.0). During activation
by rigor cross-bridges alone (9.2R) dichroism increases
slightly, but significantly (p 
 0.05), above that found in
relaxing solution (9.2). This small increase of dichroism
with rigor indicates that strong cross-bridge attachment may
have a small effect on cTnC structure in the C-terminus.
These results contrast with the dichroism of 5ATR attached
at Cys-84, which increased substantially in rigor without
Ca2 (Fig. 2 A). Addition of Ca2 to trabeculae in rigor
caused an increase in dichroism of 5ATR-labeled cTnC(C98)
that was 50% of the change at pCa 4.0 and active con-
traction (Fig. 2 B, Table 1). This result seems to indicate
that rigor cross-bridges diminish the effect of Ca2 binding
on cTnC(C98) structure. Thus, when cTnC structure is
monitored near site III by 5ATR dichroism, changes in
structure occur primarily in response to Ca2 binding, with
a smaller component due to cross-bridges, at least in rigor.
The 5ATR-labeled mono-cysteine mutant cTnC(C35)
was used to monitor the structural response of cTnC, near
inactive site I, to Ca2-activation of force and the rigor
cross-bridge state. The data are shown in Fig. 2 C. Unlike
the observations with the fluorescent probe attached to
either Cys-84 or Cys-98, the probe at Cys-35 did not indi-
cate any significant change in cTnC structure during max-
imal Ca2-activated force or rigor with (4.0R) or without
Ca2 (9.2R). Thus, the structure of cTnC near site I, as
measured by the orientation of 5ATR at Cys-35, is insen-
sitive to Ca2 binding to site II and strong cross-bridge
binding induced changes in thin filament activation. This
observation contrasts with the report that rigor cross-bridge
binding caused an increase in fluorescence in skinned car-
diac muscle reconstituted with cTnC labeled at Cys-35 with
IAANS, but agrees with the observations that Ca2 binding
and active force had no effect (Putkey et al., 1997). Because
the 5ATR probe was found to be relatively insensitive to
experimental conditions when attached to Cys-35, the re-
FIGURE 2 The effects of Ca2-activation of force and thin filament
activation by rigor cross-bridge binding are illustrated for mono-cysteine
mutants cTnC(C84) in (A), cTnC(C98) in (B), and cTnC(C35) in (C). Force
and dichroism were determined at pCa 9.2 (9.2), pCa 4.0 (4.0), rigor
without Ca2 (9.2R), and rigor with Ca2 (4.0R). The values of dichroism
(open bars) are expressed as a fraction of the value obtained in relaxing
solution (pCa 9.2), and force (filled bars) is expressed as a fraction of the
value obtained upon maximal Ca2-activation (pCa 4.0).
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mainder of the study was focused on the mono-cysteine
mutants cTnC(C84) and cTnC(C98). The changes in force
and dichroism from Fig. 2 are summarized in Table 1, along
with the absolute values of dichroism (anisotropy) at pCa
9.2 for each 5ATR-labeled mono-cysteine mutant.
The Ca2-dependence of force and dichroism
and the effects of force inhibition on
5ATR-cTnC(C84) reconstituted trabeculae
The Ca2-dependence of force and corresponding changes
in cTnC structure were measured in skinned cardiac trabec-
ulae reconstituted with 5ATR-labeled cTnC(C84) (Fig. 3).
Force and dichroism were determined at each [Ca2] as
described in Fig. 1, with particular care taken to bracket
measurements made at submaximal Ca2-activation. Force-
Ca2 and dichroism-Ca2 data from each skinned trabecu-
lae were fit by the Hill equation, and the derived Hill fit
parameters are summarized in Table 2. The pCa50 of di-
chroism was slightly greater than force, while the slopes
(nH) of force and dichroism are not significantly different.
Maximum Ca2-activated force in cTnC(C84) reconstituted
trabeculae was 97  1.6% of pre-extraction controls
(means  SEM; n  5 trabeculae).
Previous fluorescence studies of the effects of Ca2 or
strong cross-bridge binding on cTnC structure at Cys-84
used IAANS attached to native cTnC under conditions
chosen to favor labeling at Cys-84 (Hannon et al., 1992) or
with mono-cysteine cTnC(C84) (Putkey et al., 1997). To
enable comparison with dichroism data (Fig. 3), we also
determined the Ca2-dependence of force and fluorescence
in cTnC(C84)-IAANS-reconstituted skinned trabeculae. In
these preparations the pCa50 of IAANS fluorescence was
slightly more sensitive to Ca2 than was force (Table 2),
which is consistent with our previous finding (Hannon et al.,
1992). However, this differs somewhat from the conclu-
sions of Putkey et al. (1997), that the Ca2-dependence of
force and IAANS fluorescence are similar with IAANS-
labeled cTnC(C84). Differences between the Ca2-sensitiv-
ities of force and dichroism we observe for cTnC(C84)
labeled with IAANS or 5ATR (Table 2) could be due to
internal sarcomere shortening during tension development
that results from significant end-compliances in skinned
cardiac muscle. In the case of IAANS-labeled cTnC, in-
creasing internal shortening at higher forces could bring
more fluorophore into view, resulting in a component of
fluorescence that is related only to sarcomere length and not
cTnC structure, and apparent greater sensitivity of fluores-
cence to Ca2 than force. This would not be the case for
5ATR dichroism because the polarized component of
fluorescence is expressed as a fraction of the total
fluorescence.
To test for the effects of cycling cross-bridge binding on
the structure of 5ATR-labeled cTnC(C84), the Ca2-de-
pendence of dichroism (Fig. 3) was measured when force
was inhibited by 1.0 mM Vi (Figure 3, open triangle). Vi is
a phosphate analog that binds to myosin S1 (Smith and
Rayment, 1995) and is known to be a potent inhibitor of
force in both skinned skeletal (Dantzig and Goldman, 1985;
Martyn et al., 1993) and cardiac muscle (Hofmann and
Fuchs, 1987a; Wang and Fuchs, 1994, 1995). At higher
concentrations (10 mM), Vi treatment of skinned cardiac
muscle results in extraction of troponin and generation of
Ca2-insensitive force (Strauss et al., 1992). However, we
observed no elevation of resting tension or Ca2-insensitive
force in any experiment in which force was inhibited by 1.0
mM Vi, suggesting that no extraction of troponin had oc-
curred. At pCa 4.0 in the presence of 1.0 mM Vi, force was
6.0  1.0% and stiffness 10.0  3.0% (mean  SEM; n 
7 trabeculae) of the values obtained at pCa 4.0 without Vi.
For 5ATR-cTnC(C84) force inhibition resulted in a large
decrease in the pCa50 of dichroism and a significant (p 
0.05) decrease in dichroism at pCa 4.0 (Fig. 3; Table 2). It
is unlikely that the decreased maximum value and Ca2-
dependence of dichroism were the result of a direct effect of
Vi on cTnC structure because neither the dichroism at pCa
9.2 nor the total fluorescence of either 5ATR-labeled cT-
nC(C84) or cTnC(C98) reconstituted trabeculae was altered
by 1.0 mM Vi (data not shown). This is supported by the
findings that inorganic phosphate (of which Vi is an analog)
does not alter Ca2-binding to cTnC (Kentish and Palmer,
1989) and Vi decreased Ca2-binding to cTnC in cardiac
FIGURE 3 The Ca2-dependence of active force (F) and dichroism (E)
are shown for skinned trabeculae reconstituted with 5ATR-labeled cT-
nC(C84). The Ca2-dependence of dichroism is also shown following
inhibition of force with 1.0 mM Vi in the bathing solutions (‚). Data
(mean  SEM) were obtained from five fibers. Both force (solid curve)
and dichroism without (dashed lines) and with Vi (short dashed lines), data
were fit with the Hill equation. The pCa50 values and slopes (n) of the fits
are included in Table 2.
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muscle, but not the cTnC isoform in slow skeletal fibers
(Wang and Fuchs, 1994). Therefore, the observation that
force inhibition decreases both the maximum magnitude
and Ca2-sensitivity of dichroism (Fig. 3; Table 2), indicate
that when monitored at Cys-84 the structure of cTnC is
sensitive to both Ca2-binding to site II and strong, cycling
cross-bridge attachment.
The Ca2-dependence of force and dichroism
and the effects of force inhibition on
5ATR-cTnC(C98) reconstituted trabeculae
In skinned trabeculae reconstituted with 5ATR-labeled
cTnC(C98), force is slightly more sensitive to Ca2 than
dichroism (Fig. 4; Table 2). Furthermore, the Ca2-depen-
dence of force and dichroism is shifted to higher [Ca2] and
has steeper slopes than in cTnC(C84)-reconstituted prepa-
rations (Fig. 3; Table 2). Because unlabeled cTnC(C98)
caused the same shift in force-Ca2 relations (data not
shown), the decrease in the Ca2-sensitivity of force with
cTnC(C98) is likely due to the mutation of Ser-98 to Cys,
and not to the 5ATR probe. Maximum Ca2-activated
force in cTnC(C98) reconstituted trabeculae was 87 5.2%
of pre-extraction controls (mean SEM; n 5 trabeculae).
The effects of force inhibition by 1.0 mM Vi on the
Ca2-dependence of dichroism was also measured in
skinned trabeculae reconstituted with 5ATR-labeled
cTnC(C98) (Fig. 4, open triangle). Force inhibition with 1.0
mM Vi caused a decrease in the Ca2-sensitivity of dichro-
ism that was less than the decrease observed with
cTnC(C84) (Fig. 3) and no change in slope of dichroism-
Ca2 relations. Also, force inhibition with Vi caused no
significant decrease in dichroism at pCa 4.0 (p 
 0.05), in
contrast to the results with cTnC(C84) (Fig. 3). The Hill fit
parameters for the data in Fig. 4 are included in Table 2.
Thus, in contrast to cTnC(C84) (Fig. 3; Table 2) force
inhibition causes a smaller decrease in the Ca2-sensitivity
of structural changes in the C-terminus of cTnC and no
change in cTnC(C98) structure at saturating [Ca2].
The data in Figs. 2 B and 4 indicate that in cTnC with Cys
engineered at site 98, the label responded mostly to Ca2
binding to regulatory site II, while the data in Figs. 2 A and
3 indicate that at Cys-84 the label responded to both Ca2
and cross-bridge binding. Experiments described in Figs. 3
and 4 were done under identical conditions. Data from both
5ATR-labeled mono-cysteine cTnC mutants suggest that
force inhibition with Vi results in a decrease in the apparent
affinity of cTnC for Ca2, and supports previous observa-
tions that force inhibition in cardiac muscle caused de-
creased thin-filament Ca2 binding (Hofmann and Fuchs,
1987b; Wang and Fuchs, 1994).
DISCUSSION
The results of this study are in accord with measurements of
Ca2-binding in skinned cardiac muscle and support the
idea that the structure of cTnC is further modified and its
TABLE 2 The calcium-dependence of force and accompanying changes in cTnC structure monitored by changes in the
dichroism of 5ATR to either Cys-84 or Cys-98, or by changes in steady-state fluorescence of IAANS attached to Cys-84
cTnC Probe [Vi] Measurement No. pK (SEM) nH (SEM) % Max#
cTnC(C84) ATR 0 Force 5 6.4  0.02 1.1  0.04 1.0
0 Dichroism 6.3  0.04 1.02  0.09 1.0
1.0 Dichroism 5 5.66  0.05 1.1  0.10 0.71  0.03
cTnC(C98) ATR 0 Force 5 5.53  0.04 3.1  0.64 1.0
0 Dichroism 5.39  0.03 1.87  0.17 1.0
1.0 Dichroism 5.15  0.02 2.17  0.17 0.93  0.01
cTnC(C84) IAANS 0 Force 4 5.56  0.05 1.33  0.15
0 Fluorescence 5.86  0.23 0.93  0.42
#Expressed as a fraction of the increase in dichroism at pCa 4.0 without 1.0 mM Vi.
FIGURE 4 The Ca2-dependence of force (F) and dichroism (E) were
determined for 5ATR-labeled cTnC(C98) reconstituted trabeculae. The
Ca2-dependence of dichroism (‚) following force inhibition with 1.0 mM
Vi is also shown. Values are the mean (SEM) for data obtained from four
skinned trabeculae. Data for force (solid line) and dichroism without
(dashed line) and with (short dashed line) Vi were fit by the Hill equation,
and the corresponding Hill parameters are included in Table 2.
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Ca2-affinity enhanced by strongly bound, cycling cross-
bridges (Hofmann and Fuchs, 1987a; Wang and Fuchs,
1994). Furthermore, we find that when measured by dichro-
ism of 5ATR attached to cTnC, the structural response of
cTnC to Ca2 and cross-bridges depends on the site of
labeling, as illustrated in Figs. 2–4. Our results are comple-
mentary to those previously obtained with IAANS-labeled
native (Hannon et al., 1992) and mono-cysteine mutants of
cTnC (Putkey et al., 1997), and extend those observations to
include structural changes monitored at the C-terminus of
cTnC in skinned cardiac trabeculae. Additionally, because
measurement of 5ATR dichroism potentially provides in-
formation about the degree of order or mobility of cTnC
domains or probe orientation, the data complement those
obtained with fluorescent probes that respond to local
changes in solvent accessibility or hydrophobicity.
Structural responses of cTnC domains to
maximal Ca2-activation of force and
rigor cross-bridges
The effects of Ca2 or strong cross-bridge binding on the
dichroism of 5ATR were different with each mono-cys-
teine mutant cTnC. With the 5ATR probe at Cys-84, rigor
cross-bridge binding (without Ca2; 9.2R) causes an in-
crease in dichroism that is nearly as large as the increase
with maximal [Ca2] and cycling cross-bridges (Fig. 2 A;
Table 1). Furthermore, saturating Ca2 in rigor (4.0R; Fig.
2 A; Table 1) caused only a small increase in dichroism
above pCa 4.0 controls, implying that the N-terminal struc-
ture of cTnC was perturbed to nearly the same extent by
either maximal Ca2-binding to site II and cycling cross-
bridges, or rigor cross-bridges alone. In contrast, rigor
cross-bridges induced only a small change at Cys-98 (Fig.
2 B; Table 1), suggesting that the C-terminal structure of
cTnC was more responsive to Ca2-binding to site II and
relatively insensitive to strong cross-bridge binding. Probes
attached at both sites responded well to Ca2 binding (pre-
sumably to regulatory site II), implying that Ca2-binding
to site II induced structure changes in both the N- and
C-terminal domains, as for skeletal sTnC (Allen et al.,
1992).
With the probe at Cys-98, addition of Ca2 in rigor
caused an increase of dichroism that is less than found for
maximum Ca2-activation of force (4.0R; Fig. 2 B). This
indicates that rigor cross-bridge attachment may reduce the
responsiveness of cTnC structure at engineered Cys-98 to
Ca2, even though the probe at the C-terminus was not
perturbed by rigor cross-bridges alone. With rigor cross-
bridge binding N-terminal structure would be significantly
perturbed (9.2R; Fig. 2 A), so that addition of saturating
Ca2 in rigor could induce less of a change in C-terminal
structure. However, the apparent differential sensitivity of
N- and C-terminal domains of cTnC to Ca2 and rigor
cross-bridge binding is difficult to explain if Ca2-binding
to site II and strong cross-bridge attachment induce exactly
the same structural changes in cTnC. If this were the case,
the response of probes attached to either domain should
respond to both Ca2 and strong cross-bridge binding.
The absence of an effect of Ca2 or strongly bound
cross-bridges on the dichroism of 5ATR-labeled cTnC(C35)
reconstituted trabeculae (Fig. 2 C) indicates that the mobil-
ity of 5ATR at Cys-35 in the nonfunctional site I of cTnC
was not perturbed during activation of force. This result is
different from that reported by Putkey et al. (1997) in which
IAANS-labeled cTnC structure was altered by rigor, but not
cycling cross-bridges. Also, activation-dependent changes
in structure near site I could occur because the N-terminus
of cTnC assumes a more “open” configuration, upon Ca2-
binding to site II in the presence of cTnI (Dong et al., 1999)
or cTnI fragments (Li et al., 1999). However, our results are
not necessarily contradictory because local changes in hy-
drophobicity resulting from Ca2-binding to site II or TnI
binding to the hydrophobic patch of cTnC (Sia et al., 1997;
Dong et al., 1999) could occur without corresponding
changes in 5ATR mobility at Cys-35. However, because
5ATR dichroism at Cys-35 was not altered by either
Ca2 or strong cross-bridge binding (Fig. 2 C; Table 1),
changes in dichroism at labeled Cys-84 or 98 likely
reflect changes in local structure and not an overall change
in Tn orientation.
The response of 5ATR-labeled cTnC to
Ca2 and cycling cross-bridges depends on the
site of labeling
The Ca2-dependence of changes dichroism measured with
5ATR attached to either Cys-84 (Fig. 3) or Cys-98 (Fig. 4)
indicates that changes in cTnC structure occur at slightly
higher [Ca2] than corresponding changes in active force.
These results contrast with those obtained when cTnC struc-
ture is monitored with IAANS attached to Cys-84, in which
fluorescence is either more sensitive to Ca2 than force
(Table 2) and Hannon et al. (1992) or have a similar
Ca2-dependence (Putkey et al., 1997). These observations
are important, because structural changes in cTnC that occur
at or near Cys-84 are likely to be central to thin-filament
activation, because this region of cTnC binds tightly to the
inhibitory C-terminal region of cTnI in the presence of Ca2
(Farah and Reinach, 1995; Solaro and Rarick, 1998). For
example, we found a small increase in the Ca2-sensitivity
of force resulting from attachment of the 5ATR probe at
C84, further indicating that perturbation of structure near
this critical region can cause altered function. Also, changes
in cTnC structure from Ca2-binding to site II or strong
cross-bridge attachment may be reported differently by en-
vironmental probes that respond to altered hydrophobicity
of the local environment, such as IAANS, and by 5ATR,
which provides information about the mobility of the probe
in its local environment. Additionally, differences between
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results with 5ATR and IAANS could also arise from the
relative sensitivity of IAANS fluorescence to sarcomere
shortening during force generation in skinned cardiac
muscle.
Inhibition of strong cross-bridge binding and force with
1.0 mM Vi enabled us to separate the effects of Ca2-
binding on cTnC structure from those induced by strong,
cycling cross-bridges. With 5ATR attached to Cys-84 the
probe responded to both Ca2 and strong, cycling cross-
bridge binding, with force inhibition causing a decrease in
both Ca2-sensitivity and maximum magnitude of dichro-
ism (Figs. 2 and 3; Table 2). This result is different from
that reported by Putkey et al. (1997), where force inhibition
with Vi caused no change in the Ca2-dependence or mag-
nitude of fluorescence from skinned trabeculae containing
IAANS-labeled mono-cysteine mutant cTnC(C84). How-
ever, the data in Fig. 3 are consistent with the decrease of
Ca2 bound to cardiac thin filaments under similar condi-
tions (Hofmann and Fuchs, 1987a; Wang and Fuchs, 1994).
Furthermore, the decrease in dichroism at pCa 4.0 following
force inhibition indicates that in the absence of cross-bridge
binding, saturating [Ca2] does not fully perturb cTnC
structure, which requires strong cross-bridge binding. This
is consistent with the observation that the N-terminal do-
main of cTnC is less perturbed by Ca2-binding than sTnC
(Sia et al., 1997; Spyracopoulos et al., 1997), and that
maximal Ca2-binding to cTnC results in a distribution of
cTnC between unperturbed and perturbed states (Dong et
al., 1996, 1997). The decrease of dichroism at pCa 4.0 (Fig.
3) and the enhancement dichroism by rigor cross-bridges of
5ATR-labeled cTnC(C84) (Fig. 2 A) support the idea that
the N-terminal structure of cTnC is sensitive to both Ca2
and strong cross-bridge binding. Thus the results argue that
strong cross-bridge attachment results in additional activa-
tion of cardiac thin filaments, inducing structural changes in
cTnC, even at saturating [Ca2].
In contrast to cTnC(C84), 5ATR-labeled cTnC(C98)
exhibited a smaller decrease in the Ca2-sensitivity of di-
chroism and no significant (p 0.05) decrease in dichroism
at pCa 4.0 following force inhibition (Fig. 4; Table 2). It
should be noted that while maximum Ca2-activated force
was similar for cTnC(C84) and cTnC(C98) reconstituted
trabeculae, substitution of cysteine for serine at site 98 did
cause a significant decrease in the Ca2-sensitivity of force
and dichroism (Fig. 4; Table 2), compared to 5ATR-la-
beled cTnC(C84). This implies that cTnC(C98) structure
was functionally altered from the native conformation. With
the probe at Cys-98, changes in C-terminal structure could
potentially occur in response to either Ca2-binding to the
N-terminus, as proposed for skeletal TnC (Allen et al.,
1992), or to Ca2/Mg2 exchange at C-terminal sites III and
IV (Johnson et al., 1980). However, the affinities of sites III
and IV for either Ca2 or Mg2 are much higher than site
II (Johnson et al., 1980), thus structural changes resulting
from exchange at those sites should occur at lower [Ca2].
5ATR-cTnC(C98) dichroism-Ca2 relations exhibited no
evidence of an additional transition that could be attributed
to changes in dichroism resulting from exchange at site III
and IV, even with a shift to higher [Ca2] following force
inhibition (Fig. 4). Thus, unless Ca2/Mg2 exchange in the
C-terminus is influenced by cross-bridge binding, the Ca2-
induced changes in 5ATR-cTnC(C98) dichroism result
from Ca2-binding to regulatory site II. Therefore, whether
monitored by structural changes at the C- or N-terminus of
cTnC, force inhibition in cardiac muscle decreases the ap-
parent Ca2-affinity of site II, as reported from Ca2-
binding experiments (Hofmann and Fuchs, 1987a,b; Wang
and Fuchs, 1994). These results contrast with similar exper-
iments in skinned fast skeletal fibers using sTnC labeled at
Cys-98 with 5ATR (Martyn et al., 1999). Force inhibition
did not significantly change either the Ca2-sensitivity or
magnitude of dichroism, indicating that the probe responded
primarily to Ca2-binding at the N-terminus of sTnC and
that cycling cross-bridges did not induce significant struc-
tural changes in sTnC at any level of activation (Martyn et
al., 1999).
How can C- and N-terminal domains have
different responses to Ca2 and strong
cross-bridge binding?
Our results indicate that in cardiac muscle, Ca2 and cy-
cling cross-bridge binding to cardiac thin filaments may
induce different structural changes in the C- and N-terminus
of cTnC. This differential responsiveness of cTnC domains
could reflect differences in domain interactions between
cTnC and cTnI, or even with cTnT. This might not be
unexpected, because Ca2-binding to site II on cTnC causes
thin-filament activation by increasing the affinity of cTnC
for cTnI, effectively relieving acto-myosin inhibition by
competing with actin for the inhibitory domains of cTnI
(Farah and Reinach, 1995; Tobacman, 1996; Solaro and
Rarick, 1998). However, cross-bridge binding could di-
rectly displace Tm on the surface of myosin and thus alter
cTnC structure by altering its interactions with cTnI or
cTnT. As suggested above, the sensitivity of C-terminal
structure to Ca2-binding to site II, but not strong cross-
bridge binding, is difficult to explain unless Ca2-binding
to site II on cTnC and cross-bridge binding to thin filaments
induce different structural states in cTnC. Recent observa-
tions indicate that different regions of skeletal TnI bind to
the N- or C-terminal domains of skeletal TnC in a Ca2-
dependent manner (Tripet et al., 1997), and thus offer a
possible explanation for this differential sensitivity. The
C-terminus of skeletal TnI has two actin binding sites, one
(residues 96–115) that binds to the C-terminus of TnC, and
another (residues 140–148) that binds to the N-terminus of
TnC; an intervening sequence binds to the hydrophobic
patch of TnC in the presence of Ca2 (Tripet et al., 1997).
Equivalent TnC binding sequences on cTnI (Leszyk et al.,
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1988) and skeletal TnI (Wilkinson and Grand, 1975; Sheng
et al., 1992) are nearly identical. If the N- and C-terminal
domains of cTnC bind different regions of cTnI during
Ca2-activation, then the effects of Ca2 monitored at the
C-terminus of cTnC could indicate only local changes in
C-terminal, and not necessarily N-terminal, structure. Fur-
thermore, if the two domains do not act in concert the
N-terminus could be perturbed by Ca2 and cross-bridges,
and the C-terminus respond only to Ca2, as we observe.
Thus, although both Ca2 binding to cTnC and cycling
cross-bridge interaction lead to thin-filament activation in
cardiac muscle, presumably by shifting the position of tro-
pomyosin to the “on” state (McKillop and Geeves, 1993),
cross-bridge binding appears to alter the Ca2-binding
properties of cardiac TnC by preferentially perturbing N-
terminal structure.
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